Charles River Laboratories International (CRL) Other Accumulated Expenses (2009 - 2026)

Charles River Laboratories International has reported Other Accumulated Expenses for 18 years, with the latest figure at $222.8 million in Q2 2026.

• On a quarterly basis, Other Accumulated Expenses rose 7.51% year-over-year to $222.8 million in Q2 2026; TTM through Jun 2026 was $222.8 million, a 7.51% increase from a year earlier, with the FY2025 full-year figure at $222.2 million, up 14.51% from the prior year.
• Other Accumulated Expenses was $222.8 million for Q2 2026 at Charles River Laboratories International, down from $226.1 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $226.1 million in Q1 2026, with the low at $144.5 million in Q1 2022.
• Average Other Accumulated Expenses over 5 years is $200.0 million, with a median of $202.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses jumped 48.47% in 2022, then declined 6.69% in 2024.
• Over 5 years, Other Accumulated Expenses stood at $204.6 million in 2022, then retreated by 0.67% to $203.2 million in 2023, then dropped by 4.53% to $194.0 million in 2024, then climbed by 14.51% to $222.2 million in 2025, then increased by 0.29% to $222.8 million in 2026.
• The last three Other Accumulated Expenses figures came in at $222.8 million (Q2 2026), $226.1 million (Q1 2026), and $222.2 million (Q4 2025), per Business Quant data.